膀胱肿瘤整块切除术与传统经尿道膀胱肿瘤电切术的国际多中心随机对照试验:膀胱尿路上皮癌整块切除术(EBRUC)II试验首次结果
这项在7家欧洲医院开展的单盲随机对照试验将97例初诊非肌层浸润性膀胱癌患者术中按1:1随机分至整块切除术(ERBT)组57例或传统电切术(cTURBT)组40例,比较切除质量、分期质量与安全性。两组标本存在逼尿肌的比例无差异,ERBT组膀胱穿孔显著更多(7例 vs 0例,P=0.020),总体并发症率无显著差异,术后6个月复发率相当;因安全性担忧该试验提前终止。
要点
- ERBT组膀胱穿孔显著多于cTURBT组(7例 vs 0例,P=0.020),总体并发症率无显著差异(18.2% vs 7.5%,P=0.142)。
- 标本存在逼尿肌比例cTURBT组73.7% vs ERBT组67.3%,无差异(P=0.69)。
- 平均手术时间ERBT组27.6分钟 vs cTURBT组25.4分钟(P=0.450),平均切除时间16.3分钟 vs 15.5分钟(P=0.732)。
核心结论
- ERBT的可行性高于既往报道,其他围手术期与安全性参数与cTURBT相当。
- ERBT组膀胱穿孔显著更多,引发安全性担忧,该试验因此终止。
研究设计与样本
- 在7家欧洲医院开展的单盲随机对照试验,纳入标准为初诊非肌层浸润性膀胱癌、无单发原位癌、肿瘤大小>4.3 mm。
- 患者术中按1:1比例随机分至ERBT组或cTURBT组,共97例(cTURBT组40例,ERBT组57例)。
- 采用卡方检验、t检验和多因素回归分析进行结局分析。
主要发现
- 2例患者(3.5%)需要转为cTURBT,11.5%的筛查患者因ERBT术前排除。
- 标本存在逼尿肌比例cTURBT组73.7% vs ERBT组67.3%,无差异(P=0.69)。
- 平均手术时间ERBT组27.6分钟 vs cTURBT组25.4分钟(P=0.450),平均切除时间ERBT组16.3分钟 vs cTURBT组15.5分钟(P=0.732)。
- 总体并发症率ERBT组18.2% vs cTURBT组7.5%,无显著差异(P=0.142)。
- 膀胱穿孔ERBT组7例 vs cTURBT组0例,ERBT组显著更多(P=0.020)。
临床怎么用
- 原文结论指出ERBT可行性高于既往报道,其他围手术期与安全性参数与cTURBT相当。
- 原文结论指出ERBT组膀胱穿孔显著更多并引发安全性担忧,该试验因此终止。
局限性
- 该试验因ERBT组膀胱穿孔显著更多引发的安全性担忧而终止。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To determine the safety and oncological advantages of en bloc resection of bladder tumour (ERBT) vs conventional transurethral resection of bladder tumour (cTURBT) in terms of resection quality, staging quality, and safety. PATIENTS AND METHODS: We conducted a single-blinded randomised controlled trial at seven European hospitals with the following inclusion criteria: first diagnosis of non-muscle-invasive bladder cancer, no singular carcinoma in situ, and tumour size >4.3 mm. Patients were randomised intraoperatively in a 1:1 ratio to either the ERBT or cTURBT group. Outcome analysis was performed using the chi-square test, t-test, and multivariate regression analysis. RESULTS: A total of 97 patients were randomised into the study (cTURBT = 40, ERBT = 57). A switch to cTURBT was necessary in two patients (3.5%) and 11.5% of the screened patients were preoperatively excluded for ERBT. There was no difference in the specimen presence of detrusor muscle with 73.7% in cTURBT and 67.3% in ERBT specimens (P = 0.69). There were no significant differences in mean operative time (ERBT 27.6 vs cTURBT 25.4 min, P = 0.450) or mean resection time (ERBT 16.3 vs cTURBT 15.5 min, P = 0.732). Overall the complication rate did not differ significantly (ERBT 18.2% vs cTURBT 7.5%, P = 0.142). Bladder perforations occurred significantly more often in the ERBT group (ERBT seven vs cTURBT none, P = 0.020). R0 status was reported more often after ERBT, whilst a second resection was significantly less frequent after ERBT (P = 0.018). Recurrence rates were comparable for both techniques after 6 months of follow-up. CONCLUSION: The feasibility of ERBT is higher than previously reported. Whereas other perioperative and safety parameters are comparable to cTURBT, bladder perforations occurred significantly more often in the ERBT group and raised safety concerns. This is why this trial was terminated.
引用
- Struck JP, Moharam N, Leitenberger A, et al. An international multicentre randomised controlled trial of en bloc resection of bladder tumour vs conventional transurethral resection of bladder tumour: first results of the en bloc resection of urothelium carcinoma of the bladder (EBRUC) II trial. BJU Int. 2024. PMID: 39462182. doi:10.1111/bju.16543
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。